Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020
07:00pm, Monday, 04'th May 2020
SAN DIEGO, May 04, 2020 -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on.
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
12:39pm, Monday, 04'th May 2020
Arcturus Therapeutics Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (CTLT), the lead
Medical, tech investments pay off in Covid-19 war
09:00pm, Saturday, 02'nd May 2020
The world is fighting a war against a virus and Singapore scientists are pulling their weight when it comes to building up an arsenal of knowledge that can be used to vanquish the enemy.. Read more at
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * AstraZe
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:00am, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 28.)
AstraZeneca plc (NYSE:...
BBBY, DVAX among premarket gainers
01:22pm, Tuesday, 28'th Apr 2020
Broadwind Energy (NASDAQ:BWEN) +60%. on $19M order.TrovaGene (NASDAQ:TROV) +44% on new positive results from its ongoing Phase 1b/2 clinical trial of onvansertib in combination with FOLFIRI and Avast
10 Biggest Price Target Changes For Tuesday
12:10pm, Tuesday, 28'th Apr 2020
HC Wainwright & Co. boosted the price target for Arcturus Therapeutics Ltd (NASDAQ: ARCT) from $26 to $62. Arcturus Therapeutics closed at $30.53 on Monday.
Rosenblatt...
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) * AstraZeneca plc (NYSE: AZN) * Alnylam Pharmaceuti
96 Biggest Movers From Yesterday
08:22am, Tuesday, 28'th Apr 2020
Gainers
Naked Brand Group Limited (NASDAQ: NAKD) shares climbed 60.8% to close at $0.78 on Monday after climbing 8% on Friday.
Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares...
Mid-Afternoon Market Update: Dow Surges 350 Points; CNX Midstream Partners Shares Plummet
06:42pm, Monday, 27'th Apr 2020
Toward the end of trading Monday, the Dow traded up 1.48% to 24126.82 while the NASDAQ rose 1.17% to 8,735.79. The S&P also rose, gaining 1.52% to 2,879.73.
The U.S. is the...
AMRN, EPR among top gainers
01:21pm, Monday, 27'th Apr 2020
Axsome Therapeutics (NASDAQ:AXSM) +44% as Axsome's lead candidate successful in Alzheimer's study.Avadel Pharmaceuticals plc (NASDAQ:AVDL) +34% on positive data on lead drug.Yield10 Bioscience (NA
Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
11:00am, Monday, 27'th Apr 2020
100% of animals seroconverted by day 19 at a low dose (2 µg)LUNAR-COV19 remains on track to initiate human clinical trials this Summer SAN DIEGO, April 27, 2020 -- Arcturus.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Chemb
